A significant outbreak of Ebola is spreading through parts of central Africa, with experts warning that the United States is "simply choosing not to stop" the disease's progression due to substantial cuts in global and domestic public health initiatives. The current outbreak involves a rare Bundibugyo variant of Ebola, for which there is no cure or vaccine.

Health leaders and scientists are urgently working to track the virus's spread and implement containment measures, but the U.S. response has been notably absent. This comes after a year marked by the dismantling of the U.S. Agency for International Development (USAID), widespread layoffs at U.S. health agencies, stalled communications, and the cancellation of critical scientific research projects.

As of late May 2026, the Democratic Republic of the Congo (DRC) has reported 482 suspected cases and approximately 116 deaths since April. Uganda has recorded two cases and one death, with concerns of potential spread into neighboring South Sudan. Kristian Andersen, a professor of immunology and microbiology at Scripps Research, noted that the outbreak may have been developing for several months.

The World Health Organization (WHO) declared the outbreak a public health emergency of international concern, a designation made swiftly by Director-General Tedros Adhanom Ghebreyesus. Officials anticipate the emergency could persist for months, underscoring the urgent need for international support.

Matthew Kavanagh, director of the Center for Global Health Policy and Politics at Georgetown University, highlighted the vulnerability of the DRC's health system, which was heavily reliant on USAID funding. He described the sudden withdrawal of U.S. financial support as highly disruptive to the country's fundamental public health operations.

This situation contrasts sharply with previous U.S. engagement in global health crises. Historically, the U.S. has played a leading role in combating infectious disease outbreaks worldwide, leveraging its scientific and financial resources. The current retrenchment raises serious questions about the future of U.S. leadership in global health security.

The reduction in U.S. foreign assistance to the DRC, which reportedly dropped significantly from $1.4 billion in 2024, leaves a considerable gap in resources. This funding had supported essential healthcare services, disease surveillance, and emergency response capabilities within the DRC, making its absence particularly acute during this outbreak.

While the WHO and other international partners are mobilizing efforts, the scale of the challenge is immense. The lack of a rapid, robust response from a key global player like the United States creates significant uncertainty and potentially exacerbates the humanitarian crisis unfolding in central Africa.